The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jul. 22, 2025

Filed:

Jun. 04, 2021
Applicant:

Cancer Research Technology Limited, London, GB;

Inventors:

Geoff Macintyre, London, GB;

James Brenton, London, GB;

Anna Piskorz, London, GB;

Florian Markowetz, London, GB;

Assignee:
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
G16H 50/20 (2018.01); G16B 20/10 (2019.01); G16H 10/40 (2018.01); G16H 20/10 (2018.01);
U.S. Cl.
CPC ...
G16H 50/20 (2018.01); G16B 20/10 (2019.02); G16H 10/40 (2018.01); G16H 20/10 (2018.01);
Abstract

The present invention provides methods for predicting the treatment response of a cancer patient, using a tumour copy number profile for the patient. The method comprise analysing the copy number profile to assess whether the characteristics of at least one copy number feature are indicative of the presence of focal amplifications in the tumour genome, wherein the at least one copy number feature is selected from: copy number change-point, segment size and segment copy number. The patient is predicted as being likely to be resistant to treatment with an agent that induces the formation of micronuclei (e.g. doxorubicin) if the characteristics of the at least one copy number features are indicative of the presence of focal amplifications in the tumour genome. Also provided a related methods and systems.


Find Patent Forward Citations

Loading…